
### [MONDO:0006573](http://purl.obolibrary.org/obo/MONDO_0006573)
**Label:** lipodystrophy (disease)

**Subclasses:** [MONDO:0016584](http://purl.obolibrary.org/obo/MONDO_0016584) (mandibuloacral dysplasia), [MONDO:0010020](http://purl.obolibrary.org/obo/MONDO_0010020) (congenital generalized lipodystrophy type 2), [MONDO:0018883](http://purl.obolibrary.org/obo/MONDO_0018883) (Berardinelli-Seip congenital lipodystrophy), [MONDO:0013572](http://purl.obolibrary.org/obo/MONDO_0013572) (Keppen-Lubinsky syndrome), [MONDO:0009312](http://purl.obolibrary.org/obo/MONDO_0009312) (lipodystrophy due to peptidic growth factors deficiency), [MONDO:0007906](http://purl.obolibrary.org/obo/MONDO_0007906) (familial partial lipodystrophy, Dunnigan type), [MONDO:0015493](http://purl.obolibrary.org/obo/MONDO_0015493) (lipoatrophy with diabetes, leukomelanodermic papules, liver steatosis, and hypertrophic cardiomyopathy), [MONDO:0009557](http://purl.obolibrary.org/obo/MONDO_0009557) (mandibuloacral dysplasia with type a lipodystrophy), [MONDO:0017230](http://purl.obolibrary.org/obo/MONDO_0017230) (autosomal semi-dominant severe lipodystrophic laminopathy), [MONDO:0009910](http://purl.obolibrary.org/obo/MONDO_0009910) (Wiedemann-Rautenstrauch syndrome), [MONDO:0020087](http://purl.obolibrary.org/obo/MONDO_0020087) (genetic lipodystrophy), [MONDO:0020088](http://purl.obolibrary.org/obo/MONDO_0020088) (familial partial lipodystrophy), [MONDO:0010026](http://purl.obolibrary.org/obo/MONDO_0010026) (short syndrome), [MONDO:0014402](http://purl.obolibrary.org/obo/MONDO_0014402) (severe neurodegenerative syndrome with lipodystrophy), [MONDO:0013478](http://purl.obolibrary.org/obo/MONDO_0013478) (PLIN1-related familial partial lipodystrophy), [MONDO:0012923](http://purl.obolibrary.org/obo/MONDO_0012923) (congenital generalized lipodystrophy type 3), [MONDO:0011976](http://purl.obolibrary.org/obo/MONDO_0011976) (lipodystrophy-intellectual disability-deafness syndrome), [MONDO:0014431](http://purl.obolibrary.org/obo/MONDO_0014431) (LIPE-related familial partial lipodystrophy), [MONDO:0012074](http://purl.obolibrary.org/obo/MONDO_0012074) (mandibuloacral dysplasia with type b lipodystrophy), [MONDO:0014098](http://purl.obolibrary.org/obo/MONDO_0014098) (CIDEC-related familial partial lipodystrophy), [MONDO:0012072](http://purl.obolibrary.org/obo/MONDO_0012072) (familial partial lipodystrophy, KC6bberling type), [MONDO:0012071](http://purl.obolibrary.org/obo/MONDO_0012071) (congenital generalized lipodystrophy type 1), [MONDO:0019192](http://purl.obolibrary.org/obo/MONDO_0019192) (AKT2-related familial partial lipodystrophy), [MONDO:0013225](http://purl.obolibrary.org/obo/MONDO_0013225) (congenital generalized lipodystrophy type 4), [MONDO:0011448](http://purl.obolibrary.org/obo/MONDO_0011448) (PPARG-related familial partial lipodystrophy), 

**Corr. equiv. classes:** [OMIM:608600](http://purl.obolibrary.org/obo/OMIM_608600), [OMIM:604367](http://purl.obolibrary.org/obo/OMIM_604367), [Orphanet:280356](http://www.orpha.net/ORDO/Orphanet_280356), [Orphanet:156156](http://www.orpha.net/ORDO/Orphanet_156156), [OMIM:151660](http://purl.obolibrary.org/obo/OMIM_151660), [Orphanet:363400](http://www.orpha.net/ORDO/Orphanet_363400), [OMIM:614098](http://purl.obolibrary.org/obo/OMIM_614098), [OMIM:615980](http://purl.obolibrary.org/obo/OMIM_615980), [Orphanet:435651](http://www.orpha.net/ORDO/Orphanet_435651), [OMIM:248370](http://purl.obolibrary.org/obo/OMIM_248370), [OMIM:613327](http://purl.obolibrary.org/obo/OMIM_613327), [Orphanet:1979](http://www.orpha.net/ORDO/Orphanet_1979), [OMIM:615924](http://purl.obolibrary.org/obo/OMIM_615924), [Orphanet:90153](http://www.orpha.net/ORDO/Orphanet_90153), [Orphanet:90154](http://www.orpha.net/ORDO/Orphanet_90154), [Orphanet:3455](http://www.orpha.net/ORDO/Orphanet_3455), [Orphanet:2348](http://www.orpha.net/ORDO/Orphanet_2348), [OMIM:269880](http://purl.obolibrary.org/obo/OMIM_269880), [Orphanet:280365](http://www.orpha.net/ORDO/Orphanet_280365), [Orphanet:435628](http://www.orpha.net/ORDO/Orphanet_435628), [OMIM:608612](http://purl.obolibrary.org/obo/OMIM_608612), [Orphanet:3163](http://www.orpha.net/ORDO/Orphanet_3163), [Orphanet:50811](http://www.orpha.net/ORDO/Orphanet_50811), [OMIM:233805](http://purl.obolibrary.org/obo/OMIM_233805), [OMIM:269700](http://purl.obolibrary.org/obo/OMIM_269700), [Orphanet:435660](http://www.orpha.net/ORDO/Orphanet_435660), [Orphanet:79083](http://www.orpha.net/ORDO/Orphanet_79083), [Orphanet:79084](http://www.orpha.net/ORDO/Orphanet_79084), [OMIM:615238](http://purl.obolibrary.org/obo/OMIM_615238), [Orphanet:79085](http://www.orpha.net/ORDO/Orphanet_79085), [Orphanet:98305](http://www.orpha.net/ORDO/Orphanet_98305), [OMIM:613877](http://purl.obolibrary.org/obo/OMIM_613877), [OMIM:264090](http://purl.obolibrary.org/obo/OMIM_264090), [Orphanet:528](http://www.orpha.net/ORDO/Orphanet_528), [Orphanet:98306](http://www.orpha.net/ORDO/Orphanet_98306), [OMIM:612526](http://purl.obolibrary.org/obo/OMIM_612526), [OMIM:608154](http://purl.obolibrary.org/obo/OMIM_608154), [OMIM:608594](http://purl.obolibrary.org/obo/OMIM_608594), [Orphanet:228429](http://www.orpha.net/ORDO/Orphanet_228429), [Orphanet:2457](http://www.orpha.net/ORDO/Orphanet_2457), 

**Class expressions from DL-Learner:**

- [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 76.45%
- [HP:0009124](http://purl.obolibrary.org/obo/HP_0009124) (Abnormality of adipose tissue) 65.95%
- [HP:0003635](http://purl.obolibrary.org/obo/HP_0003635) (Loss of subcutaneous adipose tissue in limbs) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 65.00%
- [HP:0003635](http://purl.obolibrary.org/obo/HP_0003635) (Loss of subcutaneous adipose tissue in limbs) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 65.00%
- [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0003635](http://purl.obolibrary.org/obo/HP_0003635) (Loss of subcutaneous adipose tissue in limbs) 65.00%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0003635](http://purl.obolibrary.org/obo/HP_0003635) (Loss of subcutaneous adipose tissue in limbs) 65.00%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) and [HP:0003635](http://purl.obolibrary.org/obo/HP_0003635) (Loss of subcutaneous adipose tissue in limbs) 65.00%
- [HP:0000855](http://purl.obolibrary.org/obo/HP_0000855) (Insulin resistance) and [HP:0003635](http://purl.obolibrary.org/obo/HP_0003635) (Loss of subcutaneous adipose tissue in limbs) 65.00%
- [HP:0003635](http://purl.obolibrary.org/obo/HP_0003635) (Loss of subcutaneous adipose tissue in limbs) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 65.00%
- [HP:0003635](http://purl.obolibrary.org/obo/HP_0003635) (Loss of subcutaneous adipose tissue in limbs) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 65.00%
- [HP:0003635](http://purl.obolibrary.org/obo/HP_0003635) (Loss of subcutaneous adipose tissue in limbs) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 65.00%
- [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0003635](http://purl.obolibrary.org/obo/HP_0003635) (Loss of subcutaneous adipose tissue in limbs) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 65.00%
- [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0003635](http://purl.obolibrary.org/obo/HP_0003635) (Loss of subcutaneous adipose tissue in limbs) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 65.00%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0003635](http://purl.obolibrary.org/obo/HP_0003635) (Loss of subcutaneous adipose tissue in limbs) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 65.00%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0003635](http://purl.obolibrary.org/obo/HP_0003635) (Loss of subcutaneous adipose tissue in limbs) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 65.00%


